Onyx Biotec Limited IPO

NSE SME Allotment Out

Offer Date: Nov 13, 2024 - Nov 18, 2024

Exp. Premium: 6 (9.84%)

₹ 122000 /2000 Shares

*Expected Premium provided in this app is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.

Onyx Biotec IPO Details

13 Nov, 2024

Open Date

18 Nov, 2024

Close Date

19 Nov, 2024

Allotment Date

22 Nov, 2024

Listing Date

Issue Price

₹58-61 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

NSE SME

Registrar

Mas Services Limited

Market Lot

2000 Shares (₹122,000/-)

Lead Manager

Horizon Management Private Limited

Issue Size

4,810,000 shares(aggregating up to ₹29.34 Cr)

Retail Portion

35%

Subscription

198.68 times

IPO Docs

DRHP

Onyx Biotec IPO Subscription Details

As on	QIB / NII	Retail	Total
Shares Offered / Reserved	912,000 / 688,000	1,600,000	3,200,000
Day 1 - 13-11-24 06:00 PM	0.00 / 1.70 x	5.57 x	3.15 x
Day 2 - 14-11-24 06:00 PM	0.00 / 8.15 x	16.40 x	9.95 x
Day 3 - 18-11-24 06:00 PM	32.49 / 603.44 x	119.36 x	198.68 x

Total No. of Applications: 1,03,947 (Approx)

Onyx Biotec Valuations

EPS Pre IPO

₹2.28/-

EPS Post IPO

₹4.33/-

P/E Pre IPO

26.81

P/E Post IPO

14.1

RoNW

Onyx Biotec Company Financials All values are in ₹ Lakh

	31-Mar-24	31-Mar-23	31-Mar-22
Assets	7,413.58	5,872.36	3,683.84
Revenue	5,387.43	3,961.65	4,498.09
Profit After Tax	303.16	184.46	335.29

About The Company

Onyx Biotec Limited is a pharmaceutical company providing sterile water for injections. The company currently manufactures Sterile Water for Injections and serves as a pharmaceutical contract manufacturer, offering a comprehensive range of Dry Powder Injections and Dry Syrups for both the Indian and overseas markets.

The company has two manufacturing units in Solan, Himachal Pradesh. Unit I has a daily production capacity of 638,889 units of Sterile Water for Injections, while Unit II produces 40,000 units of dry powder injections and 26,667 units of dry syrup per day in a single shift.

The company clientele includes Hetero Healthcare Limited, Mankind Pharma Limited, Sun Pharmaceutical Industries Limited, Aristo Pharmaceuticals Private Limited, Macleods Pharmaceuticals Limited, Mapra Laboratories Private Limited, Axa Parenterals Limited, FDC Limited, Zuventus Healthcare Limited, Akums Drugs and Pharmaceuticals Limited, Reliance Life Sciences Limited, among others.

Onyx Biotec - Promoter(s)

Pre Issue Share Holding: %

Post Issue Share Holding: %

Company Promoter(s)

Sanjay Jain
Naresh Kumar
Fateh Pal Singh

Onyx Biotec IPO - Issue Objectives

Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use
Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections
Prepayment or repayment of all or a portion of certain loans availed by the Company
General Corporate Purposes.

Onyx Biotec IPO - FAQs

Ans. Onyx Biotec Limited IPO is a SME IPO. The issue is priced at ₹58-61 per equity share. The minimum order quantity is 2000 Shares. The IPO opens on Nov 13, 2024, and closes on Nov 18, 2024. Mas Services Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Ans. The Onyx Biotec Limited IPO opens on Nov 13, 2024 and closes on Nov 18, 2024.

Ans. The size of Onyx Biotec Limited IPO is 4,810,000 shares(aggregating up to ₹29.34 Cr).

Ans. The IPO price band is set between ₹58-61 per equity share.

Ans. To apply for Onyx Biotec Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Onyx Biotec Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Onyx Biotec Limited IPO is Nov 19, 2024.

Ans. The Onyx Biotec Limited IPO will be listed on Nov 22, 2024.

Ans. Follow the steps to check the allotment status for Onyx Biotec Limited IPO here.